GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,155 shares of the company's stock after selling 9,800 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in GE HealthCare Technologies were worth $5,641,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in GEHC. LGT Financial Advisors LLC increased its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies during the third quarter worth $26,000. Darwin Wealth Management LLC purchased a new position in GE HealthCare Technologies in the third quarter worth $31,000. Finally, Continuum Advisory LLC grew its stake in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC traded down $2.05 during midday trading on Friday, hitting $87.35. 4,214,326 shares of the company traded hands, compared to its average volume of 2,884,907. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The firm has a market cap of $39.94 billion, a P/E ratio of 20.17, a PEG ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The stock has a 50-day moving average of $86.00 and a 200-day moving average of $86.07.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on GEHC shares. Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.